Gene-based blood test for melanoma spread evaluates treatment progress
Virus expected to last long-term despite global vaccine rollout
12 February 2021Hope and frustration as US steps up pharmacy vaccinations
13 February 2021Gene-based blood test for melanoma spread evaluates treatment progress
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds.
